BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11767928)

  • 1. Replotting data for chronic beryllium disease.
    Cohen BS
    AIHAJ; 2001; 62(6):667. PubMed ID: 11767928
    [No Abstract]   [Full Text] [Related]  

  • 2. Beryllium copper alloy (2%) causes chronic beryllium disease.
    Balkissoon RC; Newman LS
    J Occup Environ Med; 1999 Apr; 41(4):304-8. PubMed ID: 10224597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beryllium contamination inside vehicles of machine shop workers.
    Sanderson WT; Henneberger PK; Martyny J; Ellis K; Mroz MM; Newman LS
    Am J Ind Med; 1999 Sep; Suppl 1():72-4. PubMed ID: 10519791
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic Beryllium Disease: The Search for a Dose-Response.
    Borak J
    J Occup Environ Med; 2016 Nov; 58(11):e355-e361. PubMed ID: 27820771
    [No Abstract]   [Full Text] [Related]  

  • 5. Beryllium hypersensitivity and chronic beryllium lung disease.
    Santo Tomas LH
    Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility and chemistry of materials encountered by beryllium mine and ore extraction workers: relation to risk.
    Deubner DC; Sabey P; Huang W; Fernandez D; Rudd A; Johnson WP; Storrs J; Larson R
    J Occup Environ Med; 2011 Oct; 53(10):1187-93. PubMed ID: 21926919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the beryllium lymphocyte transformation test and the beryllium levels in working environment.
    Yoshida T; Shima S; Nagaoka K; Taniwaki H; Wada A; Kurita H; Morita K
    Ind Health; 1997 Jul; 35(3):374-9. PubMed ID: 9248221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic beryllium disease and beryllium sensitization at Rocky Flats: a case-control study.
    Viet SM; Torma-Krajewski J; Rogers J
    AIHAJ; 2000; 61(2):244-54. PubMed ID: 10782196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
    McCawley MA; Kent MS; Berakis MT
    Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
    Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
    Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on the choice of exposure metrics as risk indicators.
    Wambach PF
    J Occup Environ Hyg; 2007 Oct; 4(10):D103-4; author reply D104-8. PubMed ID: 17763067
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
    Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
    Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Respiration biomechanics in patients with berylliosis and chronic toxico-chemical bronchitis].
    Antonova MIu; Merzlikin LA; Udalova LS; Cherniavskaia TZ
    Med Tr Prom Ekol; 2005; (9):34-6. PubMed ID: 16281368
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of beryllium sensitization and chronic beryllium disease.
    Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
    J Occup Environ Hyg; 2006 Apr; 3(4):D42-3. PubMed ID: 16507518
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant.
    Newman LS; Mroz MM; Maier LA; Daniloff EM; Balkissoon R
    J Occup Environ Med; 2001 Mar; 43(3):231-7. PubMed ID: 11285871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers.
    Stanton ML; Henneberger PK; Kent MS; Deubner DC; Kreiss K; Schuler CR
    J Occup Environ Med; 2006 Feb; 48(2):204-11. PubMed ID: 16474270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
    Cher DJ; Deubner DC; Kelsh MA; Chapman PS; Ray RM
    Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational Exposure to Beryllium. Final rule.
    Occupational Safety and Health Administration (OSHA), Department of Labor
    Fed Regist; 2017 Jan; 82(5):2470-757. PubMed ID: 28071878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent chronic beryllium disease in residents surrounding a beryllium facility: patients' information.
    Rossman MD
    Am J Respir Crit Care Med; 2009 Jan; 179(2):173. PubMed ID: 19119155
    [No Abstract]   [Full Text] [Related]  

  • 20. Systematic review: Progression of beryllium sensitization to chronic beryllium disease.
    Seidler A; Euler U; Müller-Quernheim J; Gaede KI; Latza U; Groneberg D; Letzel S
    Occup Med (Lond); 2012 Oct; 62(7):506-13. PubMed ID: 22705916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.